Angiodynamics (ANGO) Net Income towards Common Stockholders (2009 - 2026)
Angiodynamics' Net Income towards Common Stockholders was -$7.1 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with -$10.9 million a year earlier.
Powered by 
Analysis
Angiodynamics (ANGO) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Angiodynamics' Net Income towards Common Stockholders was -$32.94 million through Aug 31, 2026; for FY2026 (ended May 31, 2026), it was -$36.74 million.
- In earlier fiscal years, Net Income towards Common Stockholders was -$33.99 million in FY2025, -$184.35 million in FY2024, -$52.44 million in FY2023 and -$26.55 million in FY2022.
- Quarterly Net Income towards Common Stockholders has moved between -$187.74 million (fiscal Q3 2024) and $45.88 million (fiscal Q1 2024) over five years.
- Per Business Quant data, ANGO's Net Income towards Common Stockholders in the three fiscal quarters before Q1 2027 was -$11.41 million (Q4 2026), -$8.08 million (Q3 2026) and -$6.35 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 1.72 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 920.00 Mn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 1.24 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 522.80 Mn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 753.00 Mn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 582.00 Mn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 301.40 Mn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 321.00 Mn |
| 10 | Angiodynamics | 20.48 Mn | -146.80 Mn | 48.04 Mn | -7.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | -7.10 Mn |
| May 31, 2026 | -11.41 Mn |
| Feb 28, 2026 | -8.08 Mn |
| Nov 30, 2025 | -6.35 Mn |
| Aug 31, 2025 | -10.90 Mn |
| May 31, 2025 | -6.05 Mn |
| Feb 28, 2025 | -4.41 Mn |
| Nov 30, 2024 | -10.74 Mn |
| Aug 31, 2024 | -12.80 Mn |
| May 31, 2024 | -13.45 Mn |
| Feb 29, 2024 | -187.74 Mn |
| Nov 30, 2023 | -29.05 Mn |
| Aug 31, 2023 | 45.88 Mn |
| May 31, 2023 | -21.47 Mn |
| Feb 28, 2023 | -9.49 Mn |
| Nov 30, 2022 | -8.49 Mn |
| Aug 31, 2022 | -13.00 Mn |
| May 31, 2022 | -13.00 Mn |
| Feb 28, 2022 | -4.96 Mn |
| Nov 30, 2021 | -8.35 Mn |
API Access
Angiodynamics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ANGO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ANGO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ANGO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();